Overview
Orofaciodigital syndrome type 6 (OFD6), also known as Váradi-Papp syndrome or Váradi syndrome, is a rare autosomal recessive genetic disorder characterized by the combination of oral, facial, and digital anomalies along with cerebellar malformations. It is distinguished from other orofaciodigital syndromes primarily by the presence of a molar tooth sign on brain MRI, reflecting cerebellar vermis hypoplasia or aplasia, which places it within the spectrum of Joubert syndrome and related disorders. Mutations in several genes have been associated with this condition, including C5orf42 (also known as CPLANE1) and TMEM216. Key clinical features include oral findings such as tongue hamartomas (nodules), cleft lip and/or palate, lingual frenula, and dental anomalies. Facial features may include hypertelorism, broad nasal bridge, and midline cleft of the upper lip. Digital anomalies are prominent and include central polydactyly (Y-shaped metacarpal), preaxial and postaxial polydactyly, brachydactyly, and syndactyly. The central nervous system is significantly affected, with cerebellar vermis hypoplasia or aplasia leading to the characteristic molar tooth sign, intellectual disability of variable severity, hypotonia, and ataxia. Some patients may also have hypothalamic hamartomas and other brain malformations. There is no cure for OFD6, and management is supportive and multidisciplinary. Treatment may include surgical correction of cleft lip/palate and polydactyly, speech therapy, physical therapy for motor delays, and educational support for intellectual disability. Neurological monitoring is important given the cerebellar involvement. Genetic counseling is recommended for affected families. Prognosis varies depending on the severity of the central nervous system involvement, with some patients experiencing significant developmental delays while others have milder presentations.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Orofaciodigital syndrome type 6.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Orofaciodigital syndrome type 6 at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Orofaciodigital syndrome type 6.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Orofaciodigital syndrome type 6.
Community
No community posts yet. Be the first to share your experience with Orofaciodigital syndrome type 6.
Start the conversation →Latest news about Orofaciodigital syndrome type 6
No recent news articles for Orofaciodigital syndrome type 6.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Orofaciodigital syndrome type 6
What is Orofaciodigital syndrome type 6?
Orofaciodigital syndrome type 6 (OFD6), also known as Váradi-Papp syndrome or Váradi syndrome, is a rare autosomal recessive genetic disorder characterized by the combination of oral, facial, and digital anomalies along with cerebellar malformations. It is distinguished from other orofaciodigital syndromes primarily by the presence of a molar tooth sign on brain MRI, reflecting cerebellar vermis hypoplasia or aplasia, which places it within the spectrum of Joubert syndrome and related disorders. Mutations in several genes have been associated with this condition, including C5orf42 (also known
How is Orofaciodigital syndrome type 6 inherited?
Orofaciodigital syndrome type 6 follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Orofaciodigital syndrome type 6 typically begin?
Typical onset of Orofaciodigital syndrome type 6 is neonatal. Age of onset can vary across affected individuals.